Johnson & Johnson (JNJ) announced manufacturing, research and development, and
technology investments of more than $55 billion in the United States over the next four years. This represents a 25% increase in investment compared to the previous four years.
Joaquin Duato, CEO, Johnson & Johnson, said: "Our increased U.S. investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but manufacture cutting edge medicines to treat patients in America and around the world."
In addition to the facility in Wilson, North Carolina, the plans include: three new advanced manufacturing facilities and the expansion of several existing sites across the Medicine and MedTech businesses.
For comments and feedback: editorial@rttnews.com